Xoft Inc (Xoft), a subsidiary of iCAD Inc, is a medical device company that develops electronic brachytherapy systems for radiation oncology applications. The company offers products such as HDR x-ray source, axxent hub, axxent controllers, vaginal applicators, surface applicators, balloon applicators, cervical applicators, physics kits, flexishield and personnel protective shields, among others. It provides rigid shield, clamp and base plate, and vacuum pumps, among others. Xoft’s brachytherapy systems are used for treating early-stage breast cancer, non-melanoma skin cancer, and gynecological. The company provides support services. It has its operations in Australia, Russia, Germany, Italy, South Korea, Taiwan and others. Xoft is headquartered in San Jose, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Xoft Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Xoft Inc Company Overview
Xoft Inc Company Snapshot
Xoft Inc Pipeline Products and Ongoing Clinical Trials Overview
Xoft Inc – Pipeline Analysis Overview
Xoft Inc - Key Facts
Xoft Inc - Major Products and Services
Xoft Inc Pipeline Products by Development Stage
Xoft Inc Pipeline Products Overview
Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer
Xoft Axxent Electronic Brachytherapy System - Colorectal Cancer Product Overview
Xoft Axxent Electronic Brachytherapy System - Prostate Cancer
Xoft Axxent Electronic Brachytherapy System - Prostate Cancer Product Overview
Xoft Brain IORT System
Xoft Brain IORT System Product Overview
Xoft Inc - Key Competitors
Xoft Inc - Key Employees
Xoft Inc - Locations And Subsidiaries
Head Office
Recent Developments
Xoft Inc, Recent Developments
Feb 11, 2020: First brain tumor treated with Xoft IORT in the United States
Jan 27, 2020: iCAD Showcases Technology for Cancer “Discovery to Recovery” including ProFound AI Platform and Xoft System at Arab Health 2020 in Dubai
Sep 16, 2019: iCAD exhibiting new updates and enhanced Xoft platform at ASTRO Including Single-Fraction IORT Solution for the Treatment of Early-Stage Breast Cancer
Apr 15, 2019: iCAD wins three-system public bid with leading cancer organization in Spain, expanding European access to innovative cancer treatments with the Xoft System
Jan 07, 2019: Long-term study of 1,000 tumors demonstrates effectiveness of iCAD's Xoft Electronic Brachytherapy System for early-stage breast cancer treatment
Oct 30, 2018: Navicent Health adopts iCADs Breast Cancer Detection and Therapy Solutions to enhance patient care
Oct 23, 2018: iCAD announces new clinical data on the Xoft Electronic Brachytherapy System for early-stage breast cancer treatment demonstrating positive results
Oct 09, 2018: SUNY Upstate Medical University selects iCAD’s Xoft Electronic Brachytherapy System for early-stage breast cancer treatment
Oct 03, 2018: Sanford Health Announces Adoption of iCAD''s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
Oct 01, 2018: Independent, Long-Term Study Highlights Effectiveness of iCAD''s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment